0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Prescription Pain Relievers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-23K1679
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Prescription Pain Relievers Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Prescription Pain Relievers - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23K1679
Report
October 2024
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Prescription Pain Relievers - Market Size

The global market for Prescription Pain Relievers was estimated to be worth US$ 34290 million in 2023 and is forecast to a readjusted size of US$ 42600 million by 2030 with a CAGR of 3.3% during the forecast period 2024-2030

Prescription Pain Relievers - Market

Prescription Pain Relievers - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prescription Pain Relievers, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prescription Pain Relievers by region & country, by Type, and by Application.
The Prescription Pain Relievers market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Pain Relievers.
Market Segmentation

Scope of Prescription Pain Relievers - Market Report

Report Metric Details
Report Name Prescription Pain Relievers - Market
Forecasted market size in 2030 US$ 42600 million
CAGR 3.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Hospitals
  • Clinics
  • Drugstores
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Prescription Pain Relievers manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Prescription Pain Relievers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Prescription Pain Relievers in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Prescription Pain Relievers - Market size in 2030?

Ans: The Prescription Pain Relievers - Market size in 2030 will be US$ 42600 million.

Who are the main players in the Prescription Pain Relievers - Market report?

Ans: The main players in the Prescription Pain Relievers - Market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue

What are the Application segmentation covered in the Prescription Pain Relievers - Market report?

Ans: The Applications covered in the Prescription Pain Relievers - Market report are Hospitals, Clinics, Drugstores

What are the Type segmentation covered in the Prescription Pain Relievers - Market report?

Ans: The Types covered in the Prescription Pain Relievers - Market report are Generic Opioids, Branded Opioids, NSAIDs, Others

Recommended Reports

Pain Management

Analgesics & Opioids

Related Pharmaceuticals

1 Market Overview
1.1 Prescription Pain Relievers Product Introduction
1.2 Global Prescription Pain Relievers Market Size Forecast
1.3 Prescription Pain Relievers Market Trends & Drivers
1.3.1 Prescription Pain Relievers Industry Trends
1.3.2 Prescription Pain Relievers Market Drivers & Opportunity
1.3.3 Prescription Pain Relievers Market Challenges
1.3.4 Prescription Pain Relievers Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Prescription Pain Relievers Players Revenue Ranking (2023)
2.2 Global Prescription Pain Relievers Revenue by Company (2019-2024)
2.3 Key Companies Prescription Pain Relievers Manufacturing Base Distribution and Headquarters
2.4 Key Companies Prescription Pain Relievers Product Offered
2.5 Key Companies Time to Begin Mass Production of Prescription Pain Relievers
2.6 Prescription Pain Relievers Market Competitive Analysis
2.6.1 Prescription Pain Relievers Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Prescription Pain Relievers Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Generic Opioids
3.1.2 Branded Opioids
3.1.3 NSAIDs
3.1.4 Others
3.2 Global Prescription Pain Relievers Sales Value by Type
3.2.1 Global Prescription Pain Relievers Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Prescription Pain Relievers Sales Value, by Type (2019-2030)
3.2.3 Global Prescription Pain Relievers Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Drugstores
4.2 Global Prescription Pain Relievers Sales Value by Application
4.2.1 Global Prescription Pain Relievers Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Prescription Pain Relievers Sales Value, by Application (2019-2030)
4.2.3 Global Prescription Pain Relievers Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Prescription Pain Relievers Sales Value by Region
5.1.1 Global Prescription Pain Relievers Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Prescription Pain Relievers Sales Value by Region (2019-2024)
5.1.3 Global Prescription Pain Relievers Sales Value by Region (2025-2030)
5.1.4 Global Prescription Pain Relievers Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Prescription Pain Relievers Sales Value, 2019-2030
5.2.2 North America Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Prescription Pain Relievers Sales Value, 2019-2030
5.3.2 Europe Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Prescription Pain Relievers Sales Value, 2019-2030
5.4.2 Asia Pacific Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Prescription Pain Relievers Sales Value, 2019-2030
5.5.2 South America Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Prescription Pain Relievers Sales Value, 2019-2030
5.6.2 Middle East & Africa Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Prescription Pain Relievers Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Prescription Pain Relievers Sales Value
6.3 United States
6.3.1 United States Prescription Pain Relievers Sales Value, 2019-2030
6.3.2 United States Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Prescription Pain Relievers Sales Value, 2019-2030
6.4.2 Europe Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Prescription Pain Relievers Sales Value, 2019-2030
6.5.2 China Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.5.3 China Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Prescription Pain Relievers Sales Value, 2019-2030
6.6.2 Japan Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Prescription Pain Relievers Sales Value, 2019-2030
6.7.2 South Korea Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Prescription Pain Relievers Sales Value, 2019-2030
6.8.2 Southeast Asia Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Prescription Pain Relievers Sales Value, 2019-2030
6.9.2 India Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
6.9.3 India Prescription Pain Relievers Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer Prescription Pain Relievers Products, Services and Solutions
7.1.4 Pfizer Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 GSK
7.2.1 GSK Profile
7.2.2 GSK Main Business
7.2.3 GSK Prescription Pain Relievers Products, Services and Solutions
7.2.4 GSK Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.2.5 GSK Recent Developments
7.3 Grunenthal
7.3.1 Grunenthal Profile
7.3.2 Grunenthal Main Business
7.3.3 Grunenthal Prescription Pain Relievers Products, Services and Solutions
7.3.4 Grunenthal Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.3.5 Bayer Recent Developments
7.4 Bayer
7.4.1 Bayer Profile
7.4.2 Bayer Main Business
7.4.3 Bayer Prescription Pain Relievers Products, Services and Solutions
7.4.4 Bayer Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.4.5 Bayer Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Prescription Pain Relievers Products, Services and Solutions
7.5.4 Sanofi Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Profile
7.6.2 Eli Lilly Main Business
7.6.3 Eli Lilly Prescription Pain Relievers Products, Services and Solutions
7.6.4 Eli Lilly Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.6.5 Eli Lilly Recent Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Profile
7.7.2 AstraZeneca Main Business
7.7.3 AstraZeneca Prescription Pain Relievers Products, Services and Solutions
7.7.4 AstraZeneca Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.7.5 AstraZeneca Recent Developments
7.8 Endo
7.8.1 Endo Profile
7.8.2 Endo Main Business
7.8.3 Endo Prescription Pain Relievers Products, Services and Solutions
7.8.4 Endo Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.8.5 Endo Recent Developments
7.9 Merck
7.9.1 Merck Profile
7.9.2 Merck Main Business
7.9.3 Merck Prescription Pain Relievers Products, Services and Solutions
7.9.4 Merck Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.9.5 Merck Recent Developments
7.10 Depomed
7.10.1 Depomed Profile
7.10.2 Depomed Main Business
7.10.3 Depomed Prescription Pain Relievers Products, Services and Solutions
7.10.4 Depomed Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.10.5 Depomed Recent Developments
7.11 Yunnan Baiyao
7.11.1 Yunnan Baiyao Profile
7.11.2 Yunnan Baiyao Main Business
7.11.3 Yunnan Baiyao Prescription Pain Relievers Products, Services and Solutions
7.11.4 Yunnan Baiyao Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.11.5 Yunnan Baiyao Recent Developments
7.12 Teva
7.12.1 Teva Profile
7.12.2 Teva Main Business
7.12.3 Teva Prescription Pain Relievers Products, Services and Solutions
7.12.4 Teva Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.12.5 Teva Recent Developments
7.13 J&J
7.13.1 J&J Profile
7.13.2 J&J Main Business
7.13.3 J&J Prescription Pain Relievers Products, Services and Solutions
7.13.4 J&J Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.13.5 J&J Recent Developments
7.14 Allergan
7.14.1 Allergan Profile
7.14.2 Allergan Main Business
7.14.3 Allergan Prescription Pain Relievers Products, Services and Solutions
7.14.4 Allergan Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.14.5 Allergan Recent Developments
7.15 Purdue
7.15.1 Purdue Profile
7.15.2 Purdue Main Business
7.15.3 Purdue Prescription Pain Relievers Products, Services and Solutions
7.15.4 Purdue Prescription Pain Relievers Revenue (US$ Million) & (2019-2024)
7.15.5 Purdue Recent Developments
8 Industry Chain Analysis
8.1 Prescription Pain Relievers Industrial Chain
8.2 Prescription Pain Relievers Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Prescription Pain Relievers Sales Model
8.5.2 Sales Channel
8.5.3 Prescription Pain Relievers Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Prescription Pain Relievers Market Trends
    Table 2. Prescription Pain Relievers Market Drivers & Opportunity
    Table 3. Prescription Pain Relievers Market Challenges
    Table 4. Prescription Pain Relievers Market Restraints
    Table 5. Global Prescription Pain Relievers Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Prescription Pain Relievers Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Prescription Pain Relievers Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Prescription Pain Relievers Product Type
    Table 9. Key Companies Time to Begin Mass Production of Prescription Pain Relievers
    Table 10. Global Prescription Pain Relievers Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Prescription Pain Relievers Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Prescription Pain Relievers Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Prescription Pain Relievers Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Prescription Pain Relievers Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Prescription Pain Relievers Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Prescription Pain Relievers Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Prescription Pain Relievers Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Prescription Pain Relievers Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Prescription Pain Relievers Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Prescription Pain Relievers Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Prescription Pain Relievers Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Prescription Pain Relievers Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Prescription Pain Relievers Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Prescription Pain Relievers Sales Value by Region (2019-2024) & (%)
    Table 27. Global Prescription Pain Relievers Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Prescription Pain Relievers Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Prescription Pain Relievers Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Prescription Pain Relievers Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer Prescription Pain Relievers Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Prescription Pain Relievers Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. GSK Basic Information List
    Table 37. GSK Description and Business Overview
    Table 38. GSK Prescription Pain Relievers Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Prescription Pain Relievers Business of GSK (2019-2024)
    Table 40. GSK Recent Developments
    Table 41. Grunenthal Basic Information List
    Table 42. Grunenthal Description and Business Overview
    Table 43. Grunenthal Prescription Pain Relievers Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Prescription Pain Relievers Business of Grunenthal (2019-2024)
    Table 45. Grunenthal Recent Developments
    Table 46. Bayer Basic Information List
    Table 47. Bayer Description and Business Overview
    Table 48. Bayer Prescription Pain Relievers Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Prescription Pain Relievers Business of Bayer (2019-2024)
    Table 50. Bayer Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Prescription Pain Relievers Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Prescription Pain Relievers Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Eli Lilly Basic Information List
    Table 57. Eli Lilly Description and Business Overview
    Table 58. Eli Lilly Prescription Pain Relievers Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Prescription Pain Relievers Business of Eli Lilly (2019-2024)
    Table 60. Eli Lilly Recent Developments
    Table 61. AstraZeneca Basic Information List
    Table 62. AstraZeneca Description and Business Overview
    Table 63. AstraZeneca Prescription Pain Relievers Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Prescription Pain Relievers Business of AstraZeneca (2019-2024)
    Table 65. AstraZeneca Recent Developments
    Table 66. Endo Basic Information List
    Table 67. Endo Description and Business Overview
    Table 68. Endo Prescription Pain Relievers Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Prescription Pain Relievers Business of Endo (2019-2024)
    Table 70. Endo Recent Developments
    Table 71. Merck Basic Information List
    Table 72. Merck Description and Business Overview
    Table 73. Merck Prescription Pain Relievers Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Prescription Pain Relievers Business of Merck (2019-2024)
    Table 75. Merck Recent Developments
    Table 76. Depomed Basic Information List
    Table 77. Depomed Description and Business Overview
    Table 78. Depomed Prescription Pain Relievers Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Prescription Pain Relievers Business of Depomed (2019-2024)
    Table 80. Depomed Recent Developments
    Table 81. Yunnan Baiyao Basic Information List
    Table 82. Yunnan Baiyao Description and Business Overview
    Table 83. Yunnan Baiyao Prescription Pain Relievers Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Prescription Pain Relievers Business of Yunnan Baiyao (2019-2024)
    Table 85. Yunnan Baiyao Recent Developments
    Table 86. Teva Basic Information List
    Table 87. Teva Description and Business Overview
    Table 88. Teva Prescription Pain Relievers Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Prescription Pain Relievers Business of Teva (2019-2024)
    Table 90. Teva Recent Developments
    Table 91. J&J Basic Information List
    Table 92. J&J Description and Business Overview
    Table 93. J&J Prescription Pain Relievers Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Prescription Pain Relievers Business of J&J (2019-2024)
    Table 95. J&J Recent Developments
    Table 96. Allergan Basic Information List
    Table 97. Allergan Description and Business Overview
    Table 98. Allergan Prescription Pain Relievers Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Prescription Pain Relievers Business of Allergan (2019-2024)
    Table 100. Allergan Recent Developments
    Table 101. Purdue Basic Information List
    Table 102. Purdue Description and Business Overview
    Table 103. Purdue Prescription Pain Relievers Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Prescription Pain Relievers Business of Purdue (2019-2024)
    Table 105. Purdue Recent Developments
    Table 106. Key Raw Materials Lists
    Table 107. Raw Materials Key Suppliers Lists
    Table 108. Prescription Pain Relievers Downstream Customers
    Table 109. Prescription Pain Relievers Distributors List
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
    Table 113. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Prescription Pain Relievers Product Picture
    Figure 2. Global Prescription Pain Relievers Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 4. Prescription Pain Relievers Report Years Considered
    Figure 5. Global Prescription Pain Relievers Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prescription Pain Relievers Revenue in 2023
    Figure 7. Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Generic Opioids Picture
    Figure 9. Branded Opioids Picture
    Figure 10. NSAIDs Picture
    Figure 11. Others Picture
    Figure 12. Global Prescription Pain Relievers Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Prescription Pain Relievers Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Hospitals
    Figure 15. Product Picture of Clinics
    Figure 16. Product Picture of Drugstores
    Figure 17. Global Prescription Pain Relievers Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Prescription Pain Relievers Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Prescription Pain Relievers Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Prescription Pain Relievers Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Prescription Pain Relievers Sales Value (%), (2019-2030)
    Figure 30. United States Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Prescription Pain Relievers Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Prescription Pain Relievers Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Prescription Pain Relievers Sales Value by Application (%), 2023 VS 2030
    Figure 51. Prescription Pain Relievers Industrial Chain
    Figure 52. Prescription Pain Relievers Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS